Search research articles
Contact Us
Filters
Showing results (41-50 of 80) with videos related to
Page
of 8
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 7, 2018
Comparison of Adalimumab and Etanercept for the Treatment of Moderate to Severe Psoriasis: An Indirect Comparison Using Individual Patient Data from Randomized Trials
Kim A Papp, Min Yang, Murali Sundaram, et al.
Rheumatology (Oxford, England)
|
August 29, 2015
ASAS40 and ASDAS clinical responses in the ABILITY-1 clinical trial translate to meaningful improvements in physical function, health-related quality of life and work productivity in patients with non-radiographic axial spondyloarthritis
Désirée van der Heijde, Avani Joshi, Aileen L Pangan, et al.
Arthritis Care & Research
|
November 12, 2015
Impact of Treatment With Biologic Agents on the Use of Mechanical Devices Among Rheumatoid Arthritis Patients in a Large US Patient Registry
Vibeke Strand, Jeffrey D Greenberg, Jenny Griffith, et al.
Infectious Diseases and Therapy
|
September 24, 2017
Effect of Hepatitis C Treatment with Ombitasvir/Paritaprevir/R + Dasabuvir on Renal, Cardiovascular and Metabolic Extrahepatic Manifestations: A Post-Hoc Analysis of Phase 3 Clinical Trials
Darshan A Mehta, Eric Cohen, Mariem Charafeddine, et al.
Current Medical Research and Opinion
|
August 12, 2009
Economic burden of psoriasis compared to the general population and stratified by disease severity
Andrew P Yu, Jackson Tang, Jipan Xie, et al.
Clinical Drug Investigation
|
October 12, 2010
Effects of adalimumab versus placebo on risk of symptom worsening in psoriasis and subsequent impacts on health-related quality-of-life: analysis of pooled data from two randomized, double-blind, placebo-controlled, multicentre clinical trials
Kim A Papp, James Signorovitch, Karthik Ramakrishnan, et al.
Advances in Therapy
|
June 27, 2019
Assessing Patient Preferences for Treatment Decisions for New Direct Acting Antiviral (DAA) Therapies for Chronic Hepatitis C Virus Infections
Tania M Welzel, Min Yang, Gautam Sajeev, et al.
Dermatology (Basel, Switzerland)
|
November 27, 2009
Impact of adalimumab on symptoms of psoriatic arthritis in patients with moderate to severe psoriasis: a pooled analysis of randomized clinical trials
Philip J Mease, James Signorovitch, Andrew P Yu, et al.
Ophthalmology
|
July 11, 2017
Corticosteroid-Related Adverse Events Systematically Increase with Corticosteroid Dose in Noninfectious Intermediate, Posterior, or Panuveitis: Post Hoc Analyses from the VISUAL-1 and VISUAL-2 Trials
Eric B Suhler, Jennifer E Thorne, Manish Mittal, et al.
Journal of the American Academy of Dermatology
|
March 12, 2010
The effect of adalimumab on reducing depression symptoms in patients with moderate to severe psoriasis: a randomized clinical trial
Alan Menter, Matthias Augustin, James Signorovitch, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 80) with videos related to
Sort By:
Page
of 8
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 7, 2018
Comparison of Adalimumab and Etanercept for the Treatment of Moderate to Severe Psoriasis: An Indirect Comparison Using Individual Patient Data from Randomized Trials
Kim A Papp, Min Yang, Murali Sundaram, et al.
Rheumatology (Oxford, England)
|
August 29, 2015
ASAS40 and ASDAS clinical responses in the ABILITY-1 clinical trial translate to meaningful improvements in physical function, health-related quality of life and work productivity in patients with non-radiographic axial spondyloarthritis
Désirée van der Heijde, Avani Joshi, Aileen L Pangan, et al.
Arthritis Care & Research
|
November 12, 2015
Impact of Treatment With Biologic Agents on the Use of Mechanical Devices Among Rheumatoid Arthritis Patients in a Large US Patient Registry
Vibeke Strand, Jeffrey D Greenberg, Jenny Griffith, et al.
Infectious Diseases and Therapy
|
September 24, 2017
Effect of Hepatitis C Treatment with Ombitasvir/Paritaprevir/R + Dasabuvir on Renal, Cardiovascular and Metabolic Extrahepatic Manifestations: A Post-Hoc Analysis of Phase 3 Clinical Trials
Darshan A Mehta, Eric Cohen, Mariem Charafeddine, et al.
Current Medical Research and Opinion
|
August 12, 2009
Economic burden of psoriasis compared to the general population and stratified by disease severity
Andrew P Yu, Jackson Tang, Jipan Xie, et al.
Clinical Drug Investigation
|
October 12, 2010
Effects of adalimumab versus placebo on risk of symptom worsening in psoriasis and subsequent impacts on health-related quality-of-life: analysis of pooled data from two randomized, double-blind, placebo-controlled, multicentre clinical trials
Kim A Papp, James Signorovitch, Karthik Ramakrishnan, et al.
Advances in Therapy
|
June 27, 2019
Assessing Patient Preferences for Treatment Decisions for New Direct Acting Antiviral (DAA) Therapies for Chronic Hepatitis C Virus Infections
Tania M Welzel, Min Yang, Gautam Sajeev, et al.
Dermatology (Basel, Switzerland)
|
November 27, 2009
Impact of adalimumab on symptoms of psoriatic arthritis in patients with moderate to severe psoriasis: a pooled analysis of randomized clinical trials
Philip J Mease, James Signorovitch, Andrew P Yu, et al.
Ophthalmology
|
July 11, 2017
Corticosteroid-Related Adverse Events Systematically Increase with Corticosteroid Dose in Noninfectious Intermediate, Posterior, or Panuveitis: Post Hoc Analyses from the VISUAL-1 and VISUAL-2 Trials
Eric B Suhler, Jennifer E Thorne, Manish Mittal, et al.
Journal of the American Academy of Dermatology
|
March 12, 2010
The effect of adalimumab on reducing depression symptoms in patients with moderate to severe psoriasis: a randomized clinical trial
Alan Menter, Matthias Augustin, James Signorovitch, et al.
Page
of 8